Jagsonpal Pharmaceuticals Technical Analysis

Jagsonpal Pharmaceuticals Ltd Technical Analysis

Jagsonpal Pharmaceuticals Ltd technical analysis is gaining attention among traders and investors tracking Jagsonpal Pharmaceuticals Ltd Technical Analysis trends in the Indian stock market. Jagsonpal Pharmaceuticals Ltd (NSE: JAGSNPHARM, BSE: 507789) is currently trading at ₹168.67, showing a 0.01% move as of Wed, Mar 04, 2026.

This detailed Jagsonpal Pharmaceuticals Ltd technical analysis covers support & resistance levels, moving averages, indicators, and overall market sentiment to help investors make informed decisions.

Jagsonpal Pharmaceuticals Ltd Stock Overview

Jagsonpal Pharmaceuticals Ltd operates in the Health technology sector under the Pharmaceuticals: generic industry. With a market capitalization of ₹11.3B and a PE ratio of 27.54, Jagsonpal Pharmaceuticals Ltd remains a key stock to watch in Jagsonpal Pharmaceuticals Ltd Technical Analysis searches.

Key Metrics

• Market Cap: ₹11.3B
• PE Ratio: 27.54
• Dividend Yield: 1.48
• Sector: Health technology
• Industry: Pharmaceuticals: generic

These fundamentals play an important role in Jagsonpal Pharmaceuticals Ltd technical analysis and valuation tracking.

Jagsonpal Pharmaceuticals Ltd Support and Resistance Levels

Classic Pivot Levels

In Jagsonpal Pharmaceuticals Ltd technical analysis, pivot levels help identify potential reversal and breakout zones.

• Resistance 3: 222.06
• Resistance 2: 197.76
• Resistance 1: 183.21
• Pivot Point: 173.46
• Support 1: 158.91
• Support 2: 149.16
• Support 3: 124.86

Conditional Insight

Jagsonpal Pharmaceuticals Ltd technical analysis suggests a bearish to neutral trend as the price is below the pivot point. Immediate support is seen near 158.91 and 149.16.

Fibonacci Levels Analysis

Fibonacci levels are widely used in Jagsonpal Pharmaceuticals Ltd technical analysis to identify retracement zones.

• Fibonacci R3: 197.76
• Fibonacci R2: 188.47
• Fibonacci R1: 182.74
• Fibonacci Pivot: 173.46
• Fibonacci S1: 164.17
• Fibonacci S2: 158.44
• Fibonacci S3: 149.16

Jagsonpal Pharmaceuticals Ltd technical analysis indicates consolidation between Fibonacci pivot and resistance zones.

Jagsonpal Pharmaceuticals Ltd Moving Average Analysis

Moving averages are key indicators in Jagsonpal Pharmaceuticals Ltd technical analysis for identifying trend direction.

• 10 EMA: 169.36
• 20 EMA: 171.69
• 30 EMA: 173.90
• 50 EMA: 179.30
• 100 EMA: 191.98
• 200 EMA: 203.95

Trend Logic

Jagsonpal Pharmaceuticals Ltd technical analysis indicates bearish pressure, with price trading below key moving averages.

Long-term trend in Jagsonpal Pharmaceuticals Ltd technical analysis remains positive above 200 EMA.

Jagsonpal Pharmaceuticals Ltd Technical Indicators Overview

Momentum Indicators

• RSI: 34.71
• MACD: -3.00
• Signal: -2.28
• ADX: 18.93
• Momentum: -11.44

RSI Logic

Jagsonpal Pharmaceuticals Ltd technical analysis shows RSI in neutral range, suggesting consolidation.

MACD Logic

Jagsonpal Pharmaceuticals Ltd technical analysis indicates bearish momentum with MACD below signal line.

Jagsonpal Pharmaceuticals Ltd Overall Recommendation

• Overall Recommendation Score: -0.51
• Moving Average Recommendation: -0.93
• Other Indicators Recommendation: -0.09

Overall Jagsonpal Pharmaceuticals Ltd technical analysis sentiment remains neutral with mixed signals.

Jagsonpal Pharmaceuticals Ltd Technical Analysis Conclusion

Jagsonpal Pharmaceuticals Ltd technical analysis suggests that traders should closely monitor price action around ₹168.67 and key pivot level 173.46. Breakouts above resistance or breakdown below support will define the next trend in Jagsonpal Pharmaceuticals Ltd technical analysis.

Investors searching for Jagsonpal Pharmaceuticals Ltd Technical Analysis should track moving averages, RSI levels, and volume trends to identify potential entry and exit opportunities. As market conditions change, Jagsonpal Pharmaceuticals Ltd technical analysis will continue to play a crucial role in short-term trading and long-term investment strategies.